Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor Samples
Clinical trial NCT05171439 · UNKNOWN
Trial details
- NCT number
- NCT05171439
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2022-09-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.